ID   C146
AC   CVCL_S958
DR   GEO; GSM1448198
DR   Wikidata; Q54807857
RX   PubMed=1846553;
RX   PubMed=3435698;
RX   PubMed=3947514;
RX   PubMed=25926053;
CC   Doubling time: 16 +- 1 hours (PubMed=3947514).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D21S11: 29,32.2
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,18,19
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
RX   PubMed=1846553; DOI=10.1038/bjc.1991.14; PMCID=PMC1971664;
RA   Durrant L.G., Watson S.A., Hall A., Morris D.L.;
RT   "Co-stimulation of gastrointestinal tumour cell growth by gastrin,
RT   transforming growth factor alpha and insulin like growth factor-I.";
RL   Br. J. Cancer 63:67-70(1991).
//
RX   PubMed=3435698; DOI=10.1038/bjc.1987.277; PMCID=PMC2002417;
RA   Durrant L.G., Garnett M.C., Gallego J., Armitage N.C.M.,
RA   Ballantyne K.C., Marksman R.A., Hardcastle J.D., Baldwin R.W.;
RT   "Sensitivity of newly established colorectal cell lines to cytotoxic
RT   drugs and monoclonal antibody drug conjugates.";
RL   Br. J. Cancer 56:722-726(1987).
//
RX   PubMed=3947514; DOI=10.1038/bjc.1986.6; PMCID=PMC2001479;
RA   Durrant L.G., Robins R.A., Pimm M.V., Perkins A.C., Armitage N.C.M.,
RA   Hardcastle J.D., Baldwin R.W.;
RT   "Antigenicity of newly established colorectal carcinoma cell lines.";
RL   Br. J. Cancer 53:37-45(1986).
//
RX   PubMed=25926053; DOI=10.1038/ncomms8002;
RA   Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G.,
RA   Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S.,
RA   Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M.,
RA   Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.;
RT   "The molecular landscape of colorectal cancer cell lines unveils
RT   clinically actionable kinase targets.";
RL   Nat. Commun. 6:7002.1-7002.10(2015).
//